| Percent with positive ANA | |
| Systemic autoimmune diseases | |
| SLE | |
| Active | 98 to 100 percent |
| Remission | 90 percent |
| Scleroderma | 95 percent |
| Rheumatoid arthritis | 45 percent |
| Sjögren's syndrome | 60 percent |
| Mixed connective tissue disease | 100 percent |
| Drug-induced LE | 80 to 95 percent |
| Raynaud's phenomenon | 40 percent |
| Polymyositis/dermatomyositis | 35 percent |
| Juvenile idiopathic arthritis | 15 to 40 percent |
| Organ-specific autoimmune diseases | |
| Hashimotos thyroiditis | 50 percent |
| Graves' disease | 50 percent |
| Autoimmune hepatitis | 70 percent |
| Primary biliary cirrhosis | 50 to 70 percent |
| Infectious diseases* | |
| Viral: | |
| EBV | |
| HIV | |
| HCV | |
| Parvovirus 19 | |
| Bacterial: | |
| SBE | |
| Syphilis | |
| Malignancies* | |
| Lymphoproliferative diseases | |
| Paraneoplastic syndromes | |
| Miscellaneous diseases* | |
| Inflammatory bowel disease | |
| Interstitial pulmonary fibrosis | |
